Back to Agenda
Career Planning and Limitations for Mid- to Upper-Level Project Managers
Session Chair(s)
Mark Kryah, PMP
Executive Director, Program Team Leader, Program and Portfolio Management
Ultragenyx Pharmaceutical Inc., United States
If you have been managing R&D drug development projects for several years, what options do you have for further advancement or to continue to develop depth and expertise? If you feel that you have reached a limit or have plateaued, this forum will provide a variety of perspectives to consider as you evaluate what is next in your career.
Learning Objective : Discuss options to consider when evaluating a career path in R&D project management; Identify one or two tangible action steps in decision-making regarding continuing a career in R&D project management.
Speaker(s)
Panelist
Michele C. Livesey, MBA
Livesey Consulting, United States
Drug Development Strategy and Execution Consultant
Panelist
Tina Rarick, MBA
Angus Bio Consulting, LLC, United States
President
Panelist
Ben Quartley, PhD
Labcorp Drug Development, United States
Have an account?